戻る Agenda
Session 3 (continued): Research and Related Initiatives to Evaluate and Improve Real-World Evidence and Real-World Data
Session Chair(s)
John Concato, MD, MPH, MS
Associate Director for Real-World Evidence Analytics, OMP, CDER
FDA, United States
Delphine Saragoussi, MD, MSc
Executive Director, Real-World Evidence
PPD, part of Thermo Fisher Scientific, France
Part 2: Continue the discussion now focusing on regulatory agency perspective.
Speaker(s)
Speakers
Kenneth Quinto, MD, MPH
FDA, United States
Senior Medical Advisor for Real World Evidence Analytics, OMP, CDER
Speaker
Laura Esserman, MD, MBA
UCSF, United States
Director, Breast Care Center; Professor of Surgery and Radiology
Speaker
Michele Jonsson Funk, PhD, FISPE
University of North Carolina at Chapel Hill, United States
Associate Professor of Epidemiology; Director, Center for Pharmacoepidemiology
Speaker
Catherine Cohet, PhD
European Medicines Agency, Netherlands
Senior Pharmacoepidemiologist, Data Analytics and Methods Task Force